Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Category Archives: News & Announcements 2018

Top 20 Shareholders December 2022

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustJanuary 1, 2023

Top_Holders_Report DEC

Top 20 Shareholders November 2022

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustDecember 1, 2022

Top_Holders_Report NOV

Top 20 Shareholders 30th December 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAustJanuary 7, 2019

December Top_Holder_-_Detail_-_Single_Date

Top 20 Shareholders 14 December 2018

News & Announcements 2018By PharmAustDecember 17, 2018

Top_Holders_Report (14)Download

PharmAust Manufacturing Method Maintains Drug Potency

News & Announcements 2018By PharmAustDecember 2, 2018

440ws7dgb0lrfl

GMP Tablet Production for Clinical Trials Commences

News & Announcements 2018By PharmAustNovember 13, 2018

181113_GMP Tablet Manufacture_44070bgt7qng63

2018 AGM Results

News & Announcements 2018By PharmAustNovember 9, 2018

2018 AGM Results

2018 AGM Presentation

News & Announcements 2018By PharmAustNovember 9, 2018

2018 AGM Presentation

Top 20 Shareholders 31st October 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAustNovember 6, 2018

Top_Holder_-_Detail_-_Single_Date October

Drug Reformulation Play With Significant Potential

News & Announcements 2018, Research Notes 2018By PharmAustNovember 6, 2018

2018 11 05 PharmAust report from NDF Research This report has been commissioned and paid for by PharmAust (Company) and has been prepared by NDF Research, an Authorised Representative of BR Securities Australia Pty Ltd. The report solely reflects the views of Pitt Street Research. Any opinions, forecasts, recommendations or forward-looking statements in the report…

→123456→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER


Facebook
Facebook
fb-share-icon
Twitter
YouTube
TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
15 Mar

Pet care sector’s nothing to sniff at https://www.heraldsun.com.au/business/victoria-business/tim-boreham-australian-pet-care-sector-is-nothing-to-sniff-at/news-story/b508df6b5abc1f1271607dfaf42ccf06 via @theheraldsun

Reply on Twitter 1636148718847299584 Retweet on Twitter 1636148718847299584 2 Like on Twitter 1636148718847299584 8 Twitter 1636148718847299584
Retweet on Twitter PharmAust Retweeted
asxdecks ASX Decks @asxdecks ·
15 Mar

Pharmaust Limited $PAA $PAA.AX

New #ASX investor presentation: PharmAust Investor Webinar Presentation

Questions / feedback for ASX:PAA? Ask at https://tinyurl.com/25vr9ujv?entry.96502678=PAA

Reply on Twitter 1636120690091868161 Retweet on Twitter 1636120690091868161 2 Like on Twitter 1636120690091868161 2 Twitter 1636120690091868161
pharmaust PharmAust @pharmaust ·
15 Mar

🚨 Reminder that $PAA/@PharmAust Executive Chairman, Dr Roger Aston will be presenting TODAY as part of the free @broker_briefing Biotech & Nutrition Investor Webinar

Register here 👇
https://us06web.zoom.us/webinar/register/1716606999117/WN_Hwj9PbRTRE2qtdPZ0rtPSA

Reply on Twitter 1636115496323149824 Retweet on Twitter 1636115496323149824 2 Like on Twitter 1636115496323149824 8 Twitter 1636115496323149824
Load More
Copyright © 2023 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top